680 related articles for article (PubMed ID: 22508445)
21. [Stimuli-sensitive hydrogels and polymers. An effective tool in ocular therapeutic].
Alvarez Lorenzo C; Concheiro Nine A
Arch Soc Esp Oftalmol; 2002 Jan; 77(1):3-4. PubMed ID: 11813112
[No Abstract] [Full Text] [Related]
22. Toxicity of nanomaterials to the eye.
Prow TW
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):317-33. PubMed ID: 20077524
[TBL] [Abstract][Full Text] [Related]
23. γ-Cyclodextrin-based polypseudorotaxane hydrogels for ophthalmic delivery of flurbiprofen to treat anterior uveitis.
Fang G; Wang Q; Yang X; Qian Y; Zhang G; Tang B
Carbohydr Polym; 2022 Feb; 277():118889. PubMed ID: 34893291
[TBL] [Abstract][Full Text] [Related]
24. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
Liu LC; Chen YH; Lu DW
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
[TBL] [Abstract][Full Text] [Related]
25. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
26. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.
Short BG
Toxicol Pathol; 2008 Jan; 36(1):49-62. PubMed ID: 18337221
[TBL] [Abstract][Full Text] [Related]
27. Nanomaterial-based ophthalmic drug delivery.
Xie G; Lin S; Wu F; Liu J
Adv Drug Deliv Rev; 2023 Sep; 200():115004. PubMed ID: 37433372
[TBL] [Abstract][Full Text] [Related]
28. Delivery of therapeutics for deep-seated ocular conditions - status quo.
Nguyen H; Eng S; Ngo T; Dass CR
J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
[TBL] [Abstract][Full Text] [Related]
29. Biomimetics in drug delivery systems: A critical review.
Sheikhpour M; Barani L; Kasaeian A
J Control Release; 2017 May; 253():97-109. PubMed ID: 28322976
[TBL] [Abstract][Full Text] [Related]
30. [The use of liposomes as intravitreal drug delivery system].
Bejjani RA; Jeanny JC; Bochot A; Behar-Cohen F
J Fr Ophtalmol; 2003 Nov; 26(9):981-5. PubMed ID: 14631286
[TBL] [Abstract][Full Text] [Related]
31. Bioavailability of phytochemicals and its enhancement by drug delivery systems.
Aqil F; Munagala R; Jeyabalan J; Vadhanam MV
Cancer Lett; 2013 Jun; 334(1):133-41. PubMed ID: 23435377
[TBL] [Abstract][Full Text] [Related]
32. Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review.
Xinming L; Yingde C; Lloyd AW; Mikhalovsky SV; Sandeman SR; Howel CA; Liewen L
Cont Lens Anterior Eye; 2008 Apr; 31(2):57-64. PubMed ID: 17962066
[TBL] [Abstract][Full Text] [Related]
33. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
34. Recent patents on ocular drug delivery systems.
Conway BR
Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892
[TBL] [Abstract][Full Text] [Related]
35. Liposomes and nanotechnology in drug development: focus on ocular targets.
Honda M; Asai T; Oku N; Araki Y; Tanaka M; Ebihara N
Int J Nanomedicine; 2013; 8():495-503. PubMed ID: 23439842
[TBL] [Abstract][Full Text] [Related]
36. Contact lenses for drug delivery.
Ciolino JB; Dohlman CH; Kohane DS
Semin Ophthalmol; 2009; 24(3):156-60. PubMed ID: 19437351
[TBL] [Abstract][Full Text] [Related]
37. Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.
Attar M; Shen J; Ling KH; Tang-Liu D
Expert Opin Drug Deliv; 2005 Sep; 2(5):891-908. PubMed ID: 16296785
[TBL] [Abstract][Full Text] [Related]
38. Research progress of ophthalmic preparations of immunosuppressants.
Liu Y; Xu H; Yan N; Tang Z; Wang Q
Drug Deliv; 2023 Dec; 30(1):2175925. PubMed ID: 36762580
[TBL] [Abstract][Full Text] [Related]
39. Eye drop delivery of nano-polymeric micelle formulated genes with cornea-specific promoters.
Tong YC; Chang SF; Liu CY; Kao WW; Huang CH; Liaw J
J Gene Med; 2007 Nov; 9(11):956-66. PubMed ID: 17724775
[TBL] [Abstract][Full Text] [Related]
40. Drug delivery to the posterior segment of the eye.
Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
